ANTI-NETRIN-1-ANTIKÖRPER

European patent · EP3092003 · In force

Register entry

Publication number
EP3092003
Application number
EP15700118
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Jan 9, 2015
Published
Nov 16, 2016
Granted
Nov 6, 2019
Protection ends at the latest
Jan 8, 2035
Next annual fee due
Jan 31, 2027
IPC classes
A61K 39/395 (2006.01)
A61K 31/704 (2006.01)
C07K 16/22 (2006.01)
A61P 35/00 (2006.01)
Priority
EP 14305034 10.01.2014
PCT application
PCT/EP2015/050306 09.01.2015
PCT publication
WO2015/104360 16.07.2015
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Feb 1, 2026

    Change

    Published in Swissreg on 01.02.2026

  2. Feb 1, 2025

    Change

    Published in Swissreg on 01.02.2025

  3. Feb 1, 2024

    Change

    Published in Swissreg on 01.02.2024

  4. Feb 1, 2023

    Change

    Published in Swissreg on 01.02.2023

  5. Dec 5, 2019

    Agent entered

    Representative
    MICHELI & CIE SA, 122, Rue de Genève, Case postale 61, 1226 Thônex

    Published in Swissreg on 05.12.2019

  6. Nov 6, 2019

    Granted

    Published in Swissreg on 06.11.2019

Parties

Holder

Netris Pharma

28 rue Laennec Centre Léon Bérard, 69008 Lyon, FR

Agent

MICHELI & CIE SA

122, Rue de Genève Case postale 61, 1226 Thônex

Inventor

DELCROS, Jean-Guy

F-69006 Lyon, FR

DEAN, Yann

74160 Bossey, FR

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.